1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,440 | 1,750 | 20.08. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10.06. | BPC INSTRUMENTS AB: BPC Instruments receives ISO 9001 certification for quality management | 1 | Cision News | ||
| 26.05. | Bulletin from the Annual General Meeting of BPC Instruments AB (publ) | 1 | Cision News | ||
| 19.05. | BPC Instruments AB: BPC Instruments partners with AURI on anaerobic digestion experimentation in the United States | 809 | PR Newswire | LUND, Sweden, May 19, 2026 /PRNewswire/ -- BPC Instruments AB (publ) ("BPC") has entered a strategic collaboration with the Agricultural Utilization Research Institute ("AURI") to improve... ► Artikel lesen | |
| 06.05. | BPC Instruments AB (publ) reports results for Q1 2026 | 2 | Cision News | ||
| BPC INSTRUMENTS Aktie jetzt für 0€ handeln | |||||
| 30.04. | BPC INSTRUMENTS AB: BPC Instruments discloses preliminary figures for the first quarter of 2026 | 1 | Cision News | ||
| 29.04. | BPC Instruments AB (publ) publishes Annual Report for 2025 | 1 | Cision News | ||
| 23.04. | Notice of Annual General Meeting in BPC Instruments AB (publ) | 1 | Cision News | ||
| 17.03. | BPC INSTRUMENTS AB: BPC Instruments launches BPC Connect - a smart hub for the BPC Go platform | 2 | Cision News | ||
| 11.03. | BPC INSTRUMENTS AB: BPC Instruments launches BPC Academy to strengthen customer value and long-term engagement | 3 | Cision News | ||
| 26.02. | BPC Instruments AB: BPC Instruments reports results for 2025 | 454 | PR Newswire | LUND, Sweden, Feb. 26, 2026 /PRNewswire/ -- BPC Instruments AB (publ) hereby publishes the year-end report for the year 2025. The year-end report is available as... ► Artikel lesen | |
| 24.02. | BPC Instruments AB: BPC Instruments receives two repeat orders from Denmark within biogas applications | 856 | PR Newswire | LUND, Sweden, Feb. 24, 2026 /PRNewswire/ -- BPC Instruments AB (publ) has received two repeat orders from Denmark within biogas applications with a total value of approximately SEK 1.1 million.... ► Artikel lesen | |
| 19.02. | BPC Instruments AB: BPC Instruments secures order for BPC Blue system from global testing and certification group | 622 | PR Newswire | LUND, Sweden, Feb. 19, 2026 /PRNewswire/ -- BPC Instruments AB (publ) has received an order valued at approximately SEK 0.8 million for BPC's most advanced BPC Blue configuration, including... ► Artikel lesen | |
| 16.12.25 | BPC Instruments AB: BPC Instruments partners with SixRing to provide quality assurance for the EU and UK biomethane markets | 636 | PR Newswire | LUND, Sweden, Dec. 16, 2025 /PRNewswire/ -- BPC Instruments AB (publ) has entered into a collaboration with SixRing, the Canadian technology company behind Stimulose, a new feedstock additive... ► Artikel lesen | |
| 20.11.25 | BPC Instruments AB: BPC Instruments secures new order for several BPC Go units from a international energy group | 629 | PR Newswire | LUND, Sweden, Nov. 20, 2025 /PRNewswire/ -- BPC Instruments AB (publ) has received a new order valued at approximately SEK 0.9 million for several BPC Go units from a major international... ► Artikel lesen | |
| 12.11.25 | BPC Instruments AB: BPC Instruments reports results for the period January - September 2025 | 1.009 | PR Newswire | LUND, Sweden, Nov. 12, 2025 /PRNewswire/ -- BPC Instruments AB (publ) hereby publishes the interim report for the period January 1 - September 30, 2025. The interim report is available... ► Artikel lesen | |
| 02.09.25 | BPC Instruments AB: BPC Instruments expands into the textile sector - receives order from a global materials company | 423 | PR Newswire | LUND, Sweden, Sept. 2, 2025 /PRNewswire/ -- BPC Instruments AB (publ) is extending the industrial application of its BPC® Blue platform into the textiles & apparel sector, broadening the... ► Artikel lesen | |
| 27.08.25 | BPC Instruments AB: BPC Instruments reports results for H1 and Q2 2025 | 603 | PR Newswire | LUND, Sweden, Aug. 27, 2025 /PRNewswire/ -- BPC Instruments (publ) hereby publishes the half-year report for the period January 1 - June 30, 2025. The half-year report is available as an... ► Artikel lesen |
17 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MODERNA | 113,70 | -0,37 % | BREAKING: AKTIONÄR-Depotwert Moderna explodiert! | Ein Durchbruch der mRNA-Technologie im Bereich der Onkologie: Moderna und der Entwicklungspartner Merck & Co haben die lang ersehnten ersten Ergebnisse der Phase-3-Studie INTerpath-001 mit Intismeran... ► Artikel lesen | |
| AMYLYX PHARMACEUTICALS | 39,640 | -0,05 % | Kaum zu fassen: Die unglaubliche Biotech-Story von Amylyx Pharmaceuticals | Der Biotech-Sektor ist immer wieder für faustdicke Überraschungen gut - sowohl negativ als auch positiv. Bei Amylyx Pharmaceuticals gibt es am Dienstag keine zwei Meinungen: Die Aktie des Biotech-Unternehmens... ► Artikel lesen | |
| KINIKSA PHARMACEUTICALS | 78,47 | 0,00 % | Kiniksa Pharmaceuticals International, Plc: Kiniksa Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Portfolio Execution | - ARCALYST (rilonacept) Q2 2026 net product revenue of $243.6 million, representing ~55% year-over-year growth -- ARCALYST 2026 expected net product revenue increased to $980 - $995 million -- KPL-387... ► Artikel lesen | |
| QIAGEN | 38,735 | +3,05 % | DAX Gewinner am Mittwoch: Qiagen Aktie | Kursentwicklung und Chartanalyse | ||
| BIONTECH | 94,80 | -0,16 % | Schlafender Biotech-Riese vor der nächsten Wachstumsphase? BioNTech, Emyria und die neue Macht der Datenplattformen | ||
| PRAXIS PRECISION MEDICINES | 364,38 | -0,05 % | Raymond James raises Praxis Precision Medicines price target on pipeline outlook | ||
| APOGEE THERAPEUTICS | 134,78 | +0,02 % | AbbVie schließt Anleiheemission über 8,0 Mrd. US-Dollar zur Finanzierung der Übernahme von Apogee Therapeutics ab | ||
| NURIX THERAPEUTICS | 27,050 | 0,00 % | Biotech Stocks At 52-Week Highs - DCTH +22% On Q2 Results, ANRO, COAG, MNPR, NRIX | SOUTH SAN FRANCISCO (dpa-AFX) - The following biotech stocks reached 52-week highs on August 7, 2026, driven by key catalysts such as positive quarterly reports or upcoming conference participation.... ► Artikel lesen | |
| ADMA BIOLOGICS | 9,760 | 0,00 % | Kehoe Law Firm, P.C.: ADMA Biologics (ADMA) Shareholder Alert: Kehoe Law Firm Investigates Potential Fiduciary Duty Breaches | Philadelphia, Pennsylvania--(Newsfile Corp. - August 5, 2026) - Kehoe Law Firm, P.C. is investigating whether certain officers and directors of ADMA Biologics, Inc. ("ADMA," "ADMA Biologics," or... ► Artikel lesen | |
| ARCUTIS BIOTHERAPEUTICS | 25,360 | +0,04 % | Arcutis Biotherapeutics, Inc.: Arcutis Expands Board of Directors with Appointment of Chris Peetz | WESTLAKE VILLAGE, Calif., July 16, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovation in... ► Artikel lesen | |
| SUMMIT THERAPEUTICS | 12,430 | 0,00 % | Could Arcus Biosciences (RCUS) and Summit Therapeutics (SMMT)'s Cancer Drug Partnership Create a New Treatment Standard? | ||
| COGENT BIOSCIENCES | 35,310 | 0,00 % | Cogent Biosciences, Inc.: Cogent Biosciences Announces Submission of New Drug Application (NDA) for Bezuclastinib in Advanced Systemic Mastocytosis (AdvSM) | Submission based on results of APEX pivotal trial which demonstrated bezuclastinib objective response rate (CR+CRh+PR+CI) of 65% per mIWG criteria and 81% ORR per PPR criteria with a well-tolerated... ► Artikel lesen | |
| ENLIVEN THERAPEUTICS | 59,02 | +0,17 % | Barclays startet Coverage für Enliven Therapeutics mit "Overweight" und Kursziel von 78 Dollar | ||
| RECURSION PHARMACEUTICALS | 3,335 | -0,15 % | Recursion, Novavax and Crispr Stocks Trending in Pre-Market-Here's Why | ||
| STRUCTURE THERAPEUTICS | 50,52 | 0,00 % | Structure Therapeutics Inc.: Structure Therapeutics Appoints Matthew Lang, J.D. as Chief Operating Officer and General Counsel | SAN FRANCISCO, April 14, 2026 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for... ► Artikel lesen |
BPC INSTRUMENTS AB gehört der Branche Biotechnologie an. Die relative Kursveränderung beträgt aktuell -100,00 % bei einem Aktienkurs von 1,595 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BPC INSTRUMENTS AB finden Sie auf Wallstreet Online.